A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of phase 3 trial of the ...

Even as the global medical community continues to look for ways to cure and prevent Covid-19, a Mumbai-based pharmaceutical company has tested a nasal spray that has shown to effectively cure Covid-19 ...

Glenmark Pharmaceuticals and its strategic partner SaNOtize Research and Development Corp published their peer-reviewed Phase 3 clinical trials of their Nitric Oxide Nasal Spray (NONS) in the medical ...

Covid Nasal Spray: A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of ...

The trial evaluated a seven-day treatment of NONS plus standard of care versus placebo nasal spray and standard care in patients with symptomatic COVID-19. (Representational image: Reuters) A nasal ...

A nasal spray administered in high-risk adult Covid-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of phase 3 trial of the ...

According to a study that was published in The Lancet Regional Health Southeast Asia journal, nitric oxide nasal spray (NONS) has been shown to be efficient in reducing viral load of Covid-19 by 94% ...